Skip to main content
SpringerLink
Log in

Immunological Modulation of Human Cardiac Mast Cells

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Human mast cells, by elaborating various cytokines, chemokines and proinflammatory mediators play a complex role in several allergic and inflammatory disorders. Mast cells have been identified in human heart tissue in close proximity to the sarcolemma, in perivascular and adventitial locations and in the shoulder region of coronary atheroma. Human heart mast cells (HHMC) can be isolated from patients undergoing heart transplantation and can be immunologically activated in vitro to induce the release of tryptase, chymase, cysteinyl leukotriene C4 and prostaglandin D2. Several cytokines (e.g., stem cell factor and TNF-α) reside in secretory granules of HHMC. Mast cell density is increased in the hearts of patients with ischemic and idiopathic dilated cardiomyopathy. Cardiac mast cells might contribute to the evolution of atherosclerosis, dilated cardiomyopathy, cardiac and systemic anaphylaxis through the release of cytokines and vasoactive and proinflammatory mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Marone, G. 1995. Human Basophils and Mast Cells in Health and Disease. Vol. I. Biological Aspects. Karger, Basel.

    Google Scholar 

  2. Marone, G. 1995. Human Basophils and Mast Cells in Health and Disease. Vol. II. Clinical Aspects. Karger, Basel.

    Google Scholar 

  3. Walsh, L. J., Trinchieri, G., Waldorf, H. A., Whitaker, D., and Murphy, G. F. 1991. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88:4220-4224.

    PubMed  Google Scholar 

  4. Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P. A., Hunt, T. C., Okayama, Y., Heusser, C. H., Bullock, G. R., Church, M. K., and Holgate, S. T. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381-1386.

    PubMed  Google Scholar 

  5. Möller, A., Lippert, U., Lessmann, D., Kolde, G., Hamann, K., Welker, P., Schadendorf, D., Rosenbach, T., Luger, T., and Czarnetzki, B. M. 1993. Human mast cells produce IL-8. J. Immunol. 151:3261-3266.

    PubMed  Google Scholar 

  6. Patella, V., Marinò, I., Arbustini, E., Lampärter-Schummert, B., Verga, L., Adt, M., and Marone, G. 1998. Stem cell factor in mast cells and increased cardiac mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971-978.

    PubMed  Google Scholar 

  7. Rumsaeng, V., Cruikshank, W. W., Foster, B., Prussin, C., Kirshenbaum, A. S., Davis, T. A., Kornfeld, H., Center, D. M., and Metcalfe, D. D. 1997. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor IL-16. J. Immunol. 159:2904-2910.

    PubMed  Google Scholar 

  8. Yano, K., Yamaguchi, M., de Mora, F., Lantz, C. S, Butterfield, J. H., Costa, J. J., and Galli, S. J. 1997. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:185-193.

    PubMed  Google Scholar 

  9. Marone, G., Casolaro, V., Cirillo, R., Stellato, C., and Genovese, A. 1989. Pathophysiology of human basophils and mast cells in allergic disorders. Clin. Immunol. Immunopathol. 50:S24-S40.

    PubMed  Google Scholar 

  10. Galli, S. J. 1993. New concepts about the mast cell. New Engl. J. Med. 328:257-265.

    PubMed  Google Scholar 

  11. Patella, V., Florio, G., and Marone, G. 1999. HIV-1 gp120 induces IL-4 and IL-13 release from human FcɛRI+ cells. Science, in press.

  12. Marone, G. 1998. Asthma: recent advances. Immunol. Today 19:5-9.

    PubMed  Google Scholar 

  13. Marone, G., de Crescenzo, G., Patella, V., and Genovese A. 1998. Human cardiac mast cells and their role in severe allergic reactions. Pages 237-257, in Marone, G., Austen, K. F., Holgate, S. T., Kay, A. B., and Lichtenstein, L. M. (eds.), Asthma and Allergic Diseases, Academic Press, New York.

    Google Scholar 

  14. de Paulis, A., Valentini, G., Spadaro, G., Lupoli, S., Tirri, G., and Marone, G. 1991. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. Arthritis Rheum. 34:1289-1296.

    PubMed  Google Scholar 

  15. Patella, V., Marinò, I., Lampärter, B., Arbustini, E., Adt, M., and Marone, G. 1995. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J. Immunol. 154:2855-2865.

    PubMed  Google Scholar 

  16. Patella, V., de Crescenzo, G., Ciccarelli, A., Marinò, I., Adt, M., and Marone, G. 1995. Human heart mast cells: a definitive case of mast cell heterogeneity. Int. Arch. Allergy Immunol. 106:386-393.

    PubMed  Google Scholar 

  17. Patella, V., Marinò, I., Lampärter, B., Genovese, A., Adt, M., and Marone, G. 1995. Immunologic and non-immunologic release of histamine and tryptase from human heart mast cells. Inflammation Res. 44(S-I):S22-S23.

    Google Scholar 

  18. Marone, G., Patella, V., de Crescenzo, G., and Adt, M. 1995. Human heart mast cells in anaphylaxis and cardiovascular disease. Int. Arch. Allergy Immunol. 107:72-75.

    PubMed  Google Scholar 

  19. Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., and Schwartz, L. B. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83:4464-4468.

    PubMed  Google Scholar 

  20. Schwartz, L. B., Lewis, R. A., Seldin, D., and Austen, K. F. 1981. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126:1290-1294.

    PubMed  Google Scholar 

  21. Schwartz, L. B., Riedel, C., Caulfield, J. P., Wasserman, S. I., and Austen, K. F. 1981. Cell association of complex of chymase, heparin proteoglycan and protein after degranulation by rat mast cells. J. Immunol. 126:2071-2078.

    PubMed  Google Scholar 

  22. Marone, G., Triggiani, M., Cirillo, R., Giacummo, A., Hammarström, S., and Condorelli, M. 1986. IgE-mediated activation of human heart in vitro. Agents and Actions 18:194-196.

    PubMed  Google Scholar 

  23. Kaartinen, M., Penttilä, A., and Kovanen, P. T. 1994. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90:1669-1678.

    PubMed  Google Scholar 

  24. Kaartinen, M., Penttilä, A., Kovanen, P. T. 1994. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase-and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler. Thromb. 14:966-972.

    PubMed  Google Scholar 

  25. Urata, H., Kinoshita, A., Misono, K. S., Bumpus, F. M., and Husain, A. 1990. Identification of highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:22348-22357.

    PubMed  Google Scholar 

  26. Zeiher, A. M., Ihling, C., Pistorius, K., Schächinger, V., and Schaefer, H.-E. 1994. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 344:1405-1406.

    PubMed  Google Scholar 

  27. Kokkonen, J. O., and Kovanen, P. T. 1989. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro. J. Biol. Chem. 264:10749-10755.

    PubMed  Google Scholar 

  28. Hattori, Y., and Levi, R. 1986. Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. J. Pharm. Exp. Ther. 237:719-724.

    Google Scholar 

  29. Marone, G., Giordano, A., Cirillo, R., Triggiani, M., and Vigorito, C. 1988. Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann. N. Y. Acad. Sci. 524:321-333.

    PubMed  Google Scholar 

  30. Vigorito, C., Marone, G., and Condorelli, M. 1988. Cardiovascular effects of histamine and sulfidopeptide leukotrienes. Pages 107-123, in Marone, G., Lichtenstein, L. M., Condorelli, M., and Fauci, A. S. (eds.), Human Inflammatory Disease. Clinical Immunology. Vol. I, BC Decker Inc., Toronto, Philadelphia.

    Google Scholar 

  31. Vigorito, C., Giordano, A., Cirillo, R., Genovese, A., Rengo, F., and Marone, G. 1997. Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. Int. J. Clin. Lab. Res. 27:178-184.

    PubMed  Google Scholar 

  32. Marone, G., Casolaro, V., Paganelli, R., and Quinti, I. 1989. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J. Invest. Dermatol. 93:246-252.

    PubMed  Google Scholar 

  33. Hide, M., Francis, D. M., Grattan, C. E. H., Hakimi, J., Kochan, J. P., and Greaves, M. W. 1993. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N. Engl. J. Med. 328:1599-1604.

    PubMed  Google Scholar 

  34. Marone, G., Spadaro, G., Palumbo, C., and Condorelli, G. 1999. The anti-IgE/anti-FcɛRIα autoantibody network in allergic and autoimmune diseases. Clin. Exp. Allergy 29:17-27.

    Google Scholar 

  35. Schäfer, H., Mathey, D., Hugo, F., and Bhakdi, S. 1986. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137:1945-1949.

    PubMed  Google Scholar 

  36. Crawford, M. H., Grover, F. L., Kolb, W. P., McMahan, C. A., O'Rourke, R. A., McManus, L. M., and Pinckard, R. N. 1988. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78:1449-1458.

    PubMed  Google Scholar 

  37. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C. Jr., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., and Fearon, D. T. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science 249:146-151.

    PubMed  Google Scholar 

  38. Shandelya, S. M. L., Kuppusamy, P., Herskowitz, A., Weisfeldt, M. L., and Zweier, L. 1993. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury. Circulation 88:2812-2826.

    PubMed  Google Scholar 

  39. Ito, B. R., Engler, R. L., and del Balzo, U. 1993. Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am. J. Physiol. 264:H1346-H1354.

    PubMed  Google Scholar 

  40. del Balzo, U., Polley, M. J., and Levi, R. 1989. Cardiac anaphylaxis. Complement activation as an amplification system. Circulation Res. 65:847-857.

    PubMed  Google Scholar 

  41. Smith, P. L., Kagey-Sobotka, A., Bleecker, E. R., Traystman, R., Kaplan, A. P., Gralnick, H., Valentine, M. D., Permutt, S., and Lichtenstein, L. M. 1980. Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 66:1072-1080.

    PubMed  Google Scholar 

  42. Schulman, E. S., Post, T. J., Henson, P. M., and Giclas, P. 1988. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J. Clin. Invest. 81:918-923.

    PubMed  Google Scholar 

  43. Tsai, M., Shih, L. S., Newlands, G. F. J., Takeishi, T., Langley, K. E., Zsebo, K. M., Miller, H. R. P., Geissler, E. N., and Galli, S. J. 1991. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174:125-131.

    PubMed  Google Scholar 

  44. Columbo, M., Horowitz, E. M., Botana, L. M., MacGlashan, D. W. Jr., Bochner, B. S., Gillis, S., Zsebo, K. M., Galli, S. J., and Lichtenstein, L. M. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599-608.

    PubMed  Google Scholar 

  45. de Paulis, A., Ciccarelli, A., Cirillo, R., de Crescenzo, G., Columbo, M., and Marone, G. 1992. Modulation of human lung mast cell function by the c-kit receptor ligand. Int. Arch. Allergy Immunol. 99:326-329.

    Google Scholar 

  46. Stellato, C., Cirillo, R., de Paulis, A., Casolaro, V., Patella, V., Mastronardi, P., Mazzarella, B., and Marone, G. 1992. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 77:932-940.

    PubMed  Google Scholar 

  47. Stellato, C., de Crescenzo, G., Patella, V., Tatangelo, F., Mastronardi, P., Mazzarella, B., and Marone, G. 1996. Human basophil/mast cell releasability. XI. Heterogeneity of mediator release from human basophils and mast cells induced by contrast media (CM). J. Allergy Clin. Immunol. 97:838-850.

    PubMed  Google Scholar 

  48. Adt, M., Patella, V., Marinò, I., Lamparter, B., and Marone, G. 1994. Immunologic characterization of human heart mast cells. J. Invest. Dermatol. 103:621.

    Google Scholar 

  49. Bankl, H. C., Radaszkiewicz, T., Klappacher, G. W., Glogar, D., Sperr, W. R., Groβschmidt, K., Bankl, H., Lechner, K., and Valent, P. 1995. Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. Circulation 91:275-283.

    PubMed  Google Scholar 

  50. Kitamura, Y., Taguchi, T., Yokoyama, M., Inoue, M., Yamatodani, A., Asano, H., Koyama, T., Kanamaru, A., Hatanaka, K., and Wershil, B. K. 1986. Higher susceptibility of mast-cell-deficient W/Wv mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink. Am. J. Pathol. 122:469-480.

    PubMed  Google Scholar 

  51. Kauhanen, P., Kovanen, P. T., Reunala, T., and Lassila, R. 1998. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb. Haemost. 79:843-847.

    PubMed  Google Scholar 

  52. Pejler, G., Söderström, K., and Karlström, A. 1994. Inactivation of thrombin by a complex between rat mast-cell protease I and heparin proteoglycan. Biochem. J. 299:507-513.

    PubMed  Google Scholar 

  53. Schwartz, L. B., Bradford, T. R., Littman, B. H., and Wintroub, B. U. 1985. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135:2762-2767.

    PubMed  Google Scholar 

  54. Maier, M., Spragg, J., and Schwartz, L. B. 1983. Inactivation of human high molecular weight kininogen by mast cell tryptase. J. Immunol. 130:2352-2356.

    PubMed  Google Scholar 

  55. Sillaber, C., Bahgestanian, M., Bevec, D., Willheim, M., Agis, H., Kapiotis, S., Füreder, W., Bankl, H. C., Kiener, H. P., Speiser, W., Binder, B. R., Lechner, K., and Valent, P. 1999. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J. Immunol. 162:1032-1041.

    PubMed  Google Scholar 

  56. Bernreiter, M. 1959. Electrocardiogram of patient in anaphylactic shock. J.A.M.A. 170:1628-1630.

    Google Scholar 

  57. Booth, B. H., and Patterson, R. 1970. Electrocardiographic changes during human anaphylaxis. J.A.M.A. 211:627-631.

    PubMed  Google Scholar 

  58. Stellato, C., and Marone, G. 1995. The role of basophils and mast cells in adverse reactions to drugs used during general anesthesia. Pages 108-131, in Marone, G. (ed.), Human Basophils and Mast Cells in Health and Disease. Vol. II. Clinical Aspects, Karger, Basel.

    Google Scholar 

  59. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115-126.

    PubMed  Google Scholar 

  60. Hjelmman, G. 1952. Über das erste Auftreten der Mastzellen in einigen Geweben und Organen bei Homoembryonen mit Berücksichtigung der Zunahme dieser Zellen während der Embryonalentwicklung. Soc. Sci. Fenn. Comm. Biol. 13:1-53.

    Google Scholar 

  61. Pollack, O. J. 1957. Mast cells in the circulatory system of man. Circulation 1084-1089.

  62. Pomerance, A. 1958. Peri-arterial mast cells in coronary atheroma and thrombosis. J. Pathol. Bacteriol. 76:55-70.

    PubMed  Google Scholar 

  63. Forman, M. B., Oates, J. A., Robertson, D., Robertson, R. M., Roberts, L. J., and Virmani, R. 1985. Increased adventitial mast cells in a patient with coronary spasm. N. Engl. J. Med. 313:1138-1141.

    PubMed  Google Scholar 

  64. Kolodgie, F. D., Virmani, R., Cornhill, J. F., Herderick, E. E., and Smialek, J. 1991. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J. Am. Coll. Cardiol. 17:1553-1560.

    PubMed  Google Scholar 

  65. Kalsner, S., and Richards, R. 1984. Coronary arteries of cardiac patients are hyperactive and contain stores of amines: a mechanism for coronary spasm. Science 223:1435-1436.

    PubMed  Google Scholar 

  66. Vigorito, C., Poto, S., Picotti, G. B., Triggiani, M., and Marone, G. 1986. Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation 73:1175-1182.

    PubMed  Google Scholar 

  67. Constantinides, P. 1953. Mast cells and susceptibility to experimental atherosclerosis. Science 117:505-506.

    PubMed  Google Scholar 

  68. Bloom, G. D. 1984. A short history of the mast cell. Acta Otolaryngol. 414(Suppl.):87-92.

    Google Scholar 

  69. Kovanen, P. T. 1993. The mast cell: a potential link between inflammation and cellular cholesterol deposition in atherogenesis. Europ. Heart J. 14(Suppl. K):105-117.

    Google Scholar 

  70. Kovanen, P. T. 1995. Role of mast cells in atherosclerosis. Pages 132-170, in Marone, G. (ed.), Human Basophils and Mast Cells in Health and Disease. Vol II. Clinical Aspects, Karger, Basel.

    Google Scholar 

  71. Kovanen, P. T., Kaartinen, M., and Paavonen, T. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084-1088.

    PubMed  Google Scholar 

  72. Kokkonen, J. O., and Kovanen, P. T. 1987. Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein. Proc. Natl. Acad. Sci. USA 84:2287-2291.

    PubMed  Google Scholar 

  73. Lindstedt, K. A., Kokkonen, J. O., and Kovanen, P. T. 1992. Soluble heparin proteoglycans released from stimulate mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis. J. Lipid. Res. 33:65-75.

    PubMed  Google Scholar 

  74. Kaartinen, M., Penttilä, A., and Kovanen, P. T. 1996. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation 94:2787-2792.

    PubMed  Google Scholar 

  75. Frangogiannis, N. G., Perrard, J. L., Mendoza, L. H., Burns, A. R., Lindsey, M. L., Ballantyne, C. M., Michael, L. H., Smith, C. W., and Entman, M. L. 1998. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98:687-698.

    PubMed  Google Scholar 

  76. Frangogiannis, N. G., Lindsey, M. L., Michael, L. H., Youker, K. A., Bressler, R. B., Mendoza, L. H., Spengler, R. N., Smith, C. W., and Entman, M. L. 1998. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699-710.

    PubMed  Google Scholar 

  77. Estensen, R. D. 1984. Eosinophilic myocarditis: a role for mast cells? Arch. Pathol. Lab. Med. 108:358-359.

    PubMed  Google Scholar 

  78. Hiruta, Y., Adachi, K., Omamoto, T., Fujiura, Y., and Toshima, H. 1991. Cardiac mast cells in myocardial diseases (in Japanese). Kokyu To Junkan 39:1133-1138.

    PubMed  Google Scholar 

  79. Tai, P.-C., Spry, C. J. F., Olsen, E. G. J., Ackerman, S. J., Dunnette, S., and Gleich, G. J. 1987. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1:643-647.

    PubMed  Google Scholar 

  80. Desreumax, P., Janin, A., Dubucquoi, S., Copin, M.-C., Torpier, G., Capron, A., Capron, M., and Prin, L. 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82:1553-1560.

    PubMed  Google Scholar 

  81. Patella, V., de Crescenzo, G., Marinò, I., Genovese, A., Adt, M., Gleich, G. J., and Marone, G. 1996. Eosinophil granule proteins activate human heart mast cells. J. Immunol. 157:129-1225.

    Google Scholar 

  82. Okayama, Y., El-Lati, S. G., Leiferman, K. M., and Church, M. K. 1994. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J. Allergy Clin. Immunol. 93:900-909.

    PubMed  Google Scholar 

  83. Mukherjee, D., and Sen, S. 1991. Alteration of collagen phenotypes in ischemic cardiomyopathy. J. Clin. Invest. 88:1141-1146.

    PubMed  Google Scholar 

  84. Seibold, J. R., Giorno, R. C., and Claman, H. N. 1990. Dermal mast cells degranulation in systemic sclerosis. Arthritis Rheum. 33:1702-1709.

    PubMed  Google Scholar 

  85. Fox, C. C., Lazenby, A. J., Moore, W. C., Yardley, J. H., Bayless, T. M., and Licthenstein, L. M. 1990. Enhancements of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99:119-124.

    PubMed  Google Scholar 

  86. Kawanami, O., Ferrans, V. J., Fulmer, J. D., and Crystal, R. G. 1979. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40:717-734.

    PubMed  Google Scholar 

  87. Broide, D. H., Smith, C. M., and Wasserman, S. I. 1990. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. J. Immunol. 145:1838-1844.

    PubMed  Google Scholar 

  88. Fernex, M. 1968. The mast-cell system. Its relationship to atherosclerosis, fibrosis and eosinophils. The Williams & Wilkins Co., Baltimore.

    Google Scholar 

  89. Fauci, A. S., Harley, J. B., Roberts, W. C., Ferrans, V. J., Gralnic, H. R., and Björnson, B. H. 1982. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic and therapeutic considerations. Ann. Intern. Med. 87:78-92.

    Google Scholar 

  90. Lichtbroun, A. S., Sandhaus, L. M., Giorno, R. C., Kim, H., and Seibold, J. R. 1990. Myocardial mast cells in systemic sclerosis. A report of three fatal cases. Am. J. Med. 89:372-376.

    PubMed  Google Scholar 

  91. Hatamochi, A., Fujiwara, K., and Ueki, H. 1985. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch. Dermatol. Res. 277:60-64.

    PubMed  Google Scholar 

  92. Baud, L., Perez, J., Denis, M., and Ardaillou, R. 1987. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J. Immunol. 138:1190-1195.

    PubMed  Google Scholar 

  93. Ruoss, S. J., Hartmann, T., and Caughey, G. H. 1991. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88:493-499.

    PubMed  Google Scholar 

  94. Valent, P., Spanblöchl, E., Sperr, W. R., Sillaber, C., Zsebo, K. M., Agis, H., Strobl, H., Geissler, K., Bettelheim, P., and Lechner, K. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long term culture. Blood 80:2237-2245.

    PubMed  Google Scholar 

  95. Saito, H., Sakaguchi, N., Matsumoto, K., Tsubaki, T., Numazaki, T., Ebisawa, M., Kobayashi, M., Ozawa, R., Yanagi, H., Akasawa, A., and Iikura, Y. 1994. Growth in methylcellulose of human mast cells in hematopoietic colonies stimulated by steel factor, a c-kit ligand. Int. Arch. Allergy Immunol. 103:143-151.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Immunologia Clinica e Allergologia, Università di Napoli Federico II, Via S. Pansini 5, 80131, Napoli, Italy. Fax:

    Gianni Marone, Gennaro de Crescenzo, Giovanni Florio, Francescopaolo Granata, Valeria Dente & Arturo Genovese

Authors
  1. Gianni Marone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennaro de Crescenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giovanni Florio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francescopaolo Granata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valeria Dente
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Arturo Genovese
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marone, G., de Crescenzo, G., Florio, G. et al. Immunological Modulation of Human Cardiac Mast Cells. Neurochem Res 24, 1195–1202 (1999). https://doi.org/10.1023/A:1020776807187

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020776807187

Search

Navigation